# BioPharma Secured Investments III, S.ar.l — Form D

BioPharma Secured Investments III, S.ar.l of LUXEMBOURG, N4, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2013-07-17. The offering totals $247.8M, of which $247.8M was reported sold. Industry: Pooled Investment Fund.

## Offering

- Filed: 2013-07-17
- Form: D
- Accession: 0001580498-13-000001
- Industry: Pooled Investment Fund
- Exemptions: 06
- Total offering: $247.8M
- Amount sold: $247.8M
- Minimum investment: $100K
- Investors: 16
- Date of first sale: 2013-02-25
- Security types: fund interests
- SEC file number: 021-199818

## Issuer

- Name: BioPharma Secured Investments III, S.ar.l
- CIK: 0001580498
- Entity type: Other
- Jurisdiction: LUXEMBOURG
- Incorporated: 2013
- Address: 65 BOULEVARD GRANDE-DUCHESSE CHARLOTTE, LUXEMBOURG, N4, L1331
- Phone: 212-833-2296

## Officers, directors & promoters (3)

| Name | Role | Location |
| --- | --- | --- |
| Fanny Auenallah | Executive Officer | Luxembourg, N4 |
| David Catala | Executive Officer | Luxembourg, N4 |
| Andrew O'Shea | Executive Officer | Luxembourg, N4 |

## More

- [CIK 1580498 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1580498&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001580498-13-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.